Innovation Pharmaceuticals Inc (IPIX)

[xoc]

Isn't it interesting that the B-up trial is being held in an unknown location, almost as if a cda has been in place from the onset of this trial with a major pharma, to allow them to perhaps have direct oversight in this trial. It is feasible that results of the 2nd cohort in combination with the already good results of the first cohort are favorable enough to have the pharma reach a partnership deal even before the trial is complete. If that is the case we could be in a quiet period. It is unlikely that results are showing severe grade toxicity as during treatment for MRSA in the Brilicidin trial ,where there was great systemic absorption, such toxicity was not seen, and such an event would require immediate notification due to its material effect on Cellceutix. I remain optimistic and hope for great news shortly.